Pages that link to "Q53631799"

The following pages link to Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD. (Q53631799):

Displaying 43 items.

• Candidate gene studies of ADHD: a meta-analytic review (Q22252698) (← links)
• The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder (Q24629736) (← links)
• Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies (Q24648597) (← links)
• Animal models of attention-deficit hyperactivity disorder (Q24814868) (← links)
• Addressing the Complexity of Tourette's Syndrome through the Use of Animal Models (Q26752605) (← links)
• Interpatient variability in dexmedetomidine response: a survey of the literature (Q26994769) (← links)
• Advances in molecular genetic studies of attention deficit hyperactivity disorder in China (Q26995422) (← links)
• Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA. (Q31139562) (← links)
• Paying attention to reading: the neurobiology of reading and dyslexia (Q33374183) (← links)
• Molecular genetics of attention deficit hyperactivity disorder (Q33760330) (← links)
• Prenatal cocaine exposure enhances responsivity of locus coeruleus norepinephrine neurons: role of autoreceptors (Q33791921) (← links)
• Regional differences in cerebral perfusion associated with the alpha-2A-adrenergic receptor genotypes in attention deficit hyperactivity disorder (Q34084306) (← links)
• Personality mediation of genetic effects on Attention-Deficit/Hyperactivity Disorder (Q35001572) (← links)
• Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks (Q35132548) (← links)
• Pharmacogenetic Predictors of Methylphenidate Dose-Response in Attention-Deficit/Hyperactivity Disorder (Q35575795) (← links)
• Genotype and neuropsychological response inhibition as resilience promoters for attention-deficit/hyperactivity disorder, oppositional defiant disorder, and conduct disorder under conditions of psychosocial adversity (Q36536370) (← links)
• Stimulants: Therapeutic actions in ADHD. (Q36541590) (← links)
• The adrenergic receptor alpha-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD. (Q36547538) (← links)
• A Family Based Association Study of DRD4, DAT1, and 5HTT and Continuous Traits of Attention-Deficit Hyperactivity Disorder (Q36906092) (← links)
• Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function (Q37203807) (← links)
• Overview of Animal Models of Attention Deficit Hyperactivity Disorder (ADHD) (Q37826157) (← links)
• Genetic Variations of α2-Adrenergic Receptors Illuminate the Diversity of Receptor Functions (Q37902730) (← links)
• Animal Models of Attention-Deficit/Hyperactivity Disorder (Q37924467) (← links)
• Biochemical and genetic analyses of childhood attention deficit/hyperactivity disorder (Q38028871) (← links)
• Applications of pharmacogenetics in children with attention-deficit/hyperactivity disorder (Q38269008) (← links)
• Brain imaging genetics in ADHD and beyond - Mapping pathways from gene to disorder at different levels of complexity. (Q39118764) (← links)
• Tobacco smoking and the ADRA2A C-1291G polymorphism (Q40197322) (← links)
• Alpha-adrenoceptor gene variants and autonomic nervous system function in a young healthy Japanese population. (Q40274114) (← links)
• Adrenergic neurotransmitter system transporter and receptor genes associated with atomoxetine response in attention-deficit hyperactivity disorder children (Q43429050) (← links)
• Attention deficit hyperactivity disorder with reading disabilities: preliminary genetic findings on the involvement of the ADRA2A gene (Q45100096) (← links)
• Hyperactive behavior in a family with autosomal dominant lateral temporal lobe epilepsy caused by a mutation in the LGI1/epitempin gene. (Q45223039) (← links)
• Genetic influences on ADHD symptom dimensions: Examination of a priori candidates, gene-based tests, genome-wide variation, and SNP heritability. (Q45989549) (← links)
• Effects of the serotonin transporter (5-HTTLPR) and α2A-adrenoceptor (C-1291G) genotypes on substance use in children and adolescents: a longitudinal study (Q46616121) (← links)
• Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type (Q46804590) (← links)
• Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults (Q46906830) (← links)
• Sequence analysis of the ADRA2A coding region in children affected by attention deficit hyperactivity disorder (Q47617867) (← links)
• Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar–Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (Q47985523) (← links)
• Possible involvements of glutamate and adrenergic receptors on acute toxicity of methylphenidate in isolated hippocampus and cerebral cortex of adult rats (Q48479393) (← links)
• α2A -Adrenergic receptor polymorphisms and mRNA expression levels are associated with delay discounting in cocaine users (Q52308067) (← links)
• Possible association of the alpha-2A-adrenergic receptor gene with response time variability in attention deficit hyperactivity disorder. (Q53547683) (← links)
• The role of the ADRA2A C1291G genetic polymorphism in response to dexmedetomidine on patients undergoing coronary artery surgery (Q53692809) (← links)
• Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder (Q57217515) (← links)
• Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD (Q82586267) (← links)